DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE was reported 526 times

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANIRIDIA 1 0.0833
1 EYELID ABRASION 1 0.0526
2 INSTILLATION SITE COMPLICATION 1 0.0476
3 ARTICULAR DISC DISORDER 1 0.0270
4 CONJUNCTIVAL DEPOSIT 1 0.0213
5 OESOPHAGEAL DYSPLASIA 1 0.0192
6 COLITIS MICROSCOPIC 72 0.0152
7 PANCREATIC DUCT DILATATION 4 0.0145
8 INFECTIVE SCLERITIS 1 0.0111
9 PALPABLE PURPURA 3 0.0109
10 EYE OPACITY 1 0.0109
11 OCULAR SURFACE DISEASE 3 0.0107
12 PERIPHERAL PULSE DECREASED 1 0.0103
13 SERRATIA TEST POSITIVE 1 0.0103
14 TRACTIONAL RETINAL DETACHMENT 1 0.0090
15 TENDINOUS CONTRACTURE 1 0.0088
16 EYE NAEVUS 1 0.0088
17 SENILE OSTEOPOROSIS 1 0.0081
18 CEREBELLAR TUMOUR 1 0.0079
19 OPTIC NERVE CUPPING 1 0.0079
20 NECROTISING SCLERITIS 1 0.0069
21 RASH FOLLICULAR 1 0.0065
22 THYROXINE DECREASED 4 0.0065
23 CORNEAL DECOMPENSATION 1 0.0062
24 CARDIOACTIVE DRUG LEVEL ABOVE THERAPEUTIC 1 0.0060
25 ADMINISTRATION RELATED REACTION 1 0.0051
26 INTRAOCULAR PRESSURE FLUCTUATION 1 0.0051
27 IRIS ATROPHY 1 0.0048
28 GLAUCOMA 93 0.0048
29 LENS DISLOCATION 1 0.0048
30 HAND DEFORMITY 61 0.0046
31 EYELASH DISCOLOURATION 1 0.0046
32 THERMAL BURNS OF EYE 1 0.0044
33 KERATIC PRECIPITATES 2 0.0042
34 SCIATICA 66 0.0041
35 CORNEAL NEOVASCULARISATION 1 0.0040
36 EAR INJURY 2 0.0040
37 SYNOVITIS 72 0.0040
38 GLAUCOMA SURGERY 1 0.0039
39 DENTURE WEARER 1 0.0039
40 THYROID HORMONES INCREASED 4 0.0038
41 INTRAOCULAR PRESSURE DECREASED 2 0.0038
42 NASAL SEPTUM DISORDER 1 0.0038
43 EYELID OPERATION 1 0.0037
44 FACIAL WASTING 1 0.0037
45 FRACTURE PAIN 2 0.0037
46 EPIRETINAL MEMBRANE 1 0.0036
47 VITREOUS OPACITIES 3 0.0036
48 SKIN REACTION 50 0.0035
49 JOINT FLUID DRAINAGE 1 0.0035
50 OPHTHALMIC HERPES SIMPLEX 2 0.0035
51 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
52 EYE BURNS 2 0.0034
53 THYROID DISORDER 51 0.0033
54 OPEN ANGLE GLAUCOMA 2 0.0033
55 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 1 0.0032
56 PRODUCT DEPOSIT 5 0.0032
57 CORNEAL INFILTRATES 1 0.0032
58 INTESTINAL POLYP 5 0.0030
59 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
60 PRODUCT DESIGN ISSUE 2 0.0028
61 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
62 VENOUS PRESSURE JUGULAR INCREASED 1 0.0028
63 DIVERTICULITIS 75 0.0027
64 UROGENITAL HAEMORRHAGE 1 0.0027
65 INSTILLATION SITE IRRITATION 3 0.0025
66 VISUAL BRIGHTNESS 1 0.0025
67 BLOOD URIC ACID ABNORMAL 1 0.0025
68 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
69 TONGUE PRURITUS 2 0.0023
70 REFLUX LARYNGITIS 1 0.0023
71 EYELID INFECTION 1 0.0023
72 DEFORMITY 21 0.0022
73 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
74 PULMONARY VASCULAR DISORDER 1 0.0021
75 VITREOUS DISORDER 1 0.0021
76 ELECTROLYTE DEPLETION 1 0.0020
77 HAEMANGIOMA OF LIVER 2 0.0020
78 GLARE 1 0.0019
79 PRESBYOPIA 1 0.0018
80 BLOOD GROWTH HORMONE INCREASED 1 0.0018
81 BRAIN SCAN ABNORMAL 1 0.0018
82 SUSPECTED PRODUCT TAMPERING 1 0.0018
83 HYPORESPONSIVE TO STIMULI 2 0.0017
84 EYE LASER SURGERY 1 0.0017
85 RETINAL VASCULITIS 2 0.0017
86 THYROID CYST 1 0.0017
87 EYELID SKIN DRYNESS 2 0.0016
88 PUPILLARY DISORDER 1 0.0016
89 CATARACT SUBCAPSULAR 1 0.0016
90 PNEUMONIA KLEBSIELLA 3 0.0016
91 STERNAL FRACTURE 2 0.0016
92 VITRITIS 3 0.0016
93 JOINT WARMTH 2 0.0016
94 EYELID IRRITATION 4 0.0016
95 CORNEAL PERFORATION 1 0.0016
96 INTESTINAL ANASTOMOSIS 1 0.0016
97 CHORIORETINITIS 1 0.0016
98 CONTRAINDICATED PRODUCT ADMINISTERED 46 0.0015
99 MACULAR FIBROSIS 1 0.0015
100 CORNEAL OPACITY 2 0.0015
101 ULCERATIVE KERATITIS 4 0.0015
102 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
103 BONE EROSION 5 0.0014
104 C-REACTIVE PROTEIN INCREASED 51 0.0014
105 PRODUCT CONTAINER ISSUE 12 0.0014
106 FINE MOTOR SKILL DYSFUNCTION 4 0.0014
107 TRAUMATIC FRACTURE 1 0.0014
108 CORNEAL DEPOSITS 1 0.0013
109 PRODUCT DROPPER ISSUE 1 0.0013
110 LIP ERYTHEMA 1 0.0013
111 BARRETT'S OESOPHAGUS 1 0.0012
112 REACTION TO PRESERVATIVES 1 0.0012
113 SEROUS RETINAL DETACHMENT 1 0.0012
114 GAZE PALSY 2 0.0012
115 CHOROIDAL NEOVASCULARISATION 1 0.0012
116 HYPERSENSITIVITY VASCULITIS 3 0.0011
117 SENSATION OF PRESSURE 1 0.0011
118 TREATMENT FAILURE 93 0.0011
119 HYPERPLASIA 1 0.0011
120 CUTANEOUS VASCULITIS 4 0.0011
121 FOOD INTOLERANCE 4 0.0011
122 PUNCTATE KERATITIS 1 0.0011
123 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
124 BRONCHITIS 77 0.0010
125 OCULAR HYPERTENSION 2 0.0010
126 EYE COLOUR CHANGE 1 0.0010
127 CAROTID ARTERIOSCLEROSIS 1 0.0010
128 SPINAL STENOSIS 4 0.0010
129 EYELIDS PRURITUS 3 0.0010
130 URETEROLITHIASIS 1 0.0010
131 HYPOPERFUSION 1 0.0010
132 SYSTOLIC DYSFUNCTION 1 0.0009
133 FOREIGN BODY SENSATION IN EYES 6 0.0009
134 INTRAOCULAR PRESSURE INCREASED 12 0.0009
135 PRODUCT DELIVERY MECHANISM ISSUE 5 0.0009
136 GALLBLADDER ENLARGEMENT 1 0.0009
137 AORTIC DILATATION 1 0.0009
138 PERIARTHRITIS 2 0.0009
139 PUPILS UNEQUAL 1 0.0009
140 INJECTION SITE REACTION 60 0.0009
141 ORAL PRURITUS 2 0.0009
142 ACUTE PRERENAL FAILURE 1 0.0009
143 LUMBAR RADICULOPATHY 1 0.0009
144 MACROCYTOSIS 1 0.0009
145 DILATATION ATRIAL 1 0.0009
146 PATELLA FRACTURE 2 0.0009
147 EYE IRRITATION 49 0.0009
148 CONJUNCTIVAL HYPERAEMIA 3 0.0008
149 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
150 ORAL MUCOSA EROSION 1 0.0008
151 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
152 VICTIM OF CRIME 1 0.0008
153 DRUG INTOLERANCE 78 0.0008
154 INSTILLATION SITE PAIN 2 0.0008
155 LABYRINTHITIS 2 0.0008
156 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
157 SINUS ARRHYTHMIA 1 0.0008
158 ANAEMIA POSTOPERATIVE 1 0.0008
159 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
160 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
161 HEPATIC ENZYME INCREASED 51 0.0007
162 CORNEAL ABRASION 1 0.0007
163 CARDIOVERSION 1 0.0007
164 BRONCHIAL OBSTRUCTION 1 0.0007
165 RETINAL VEIN OCCLUSION 2 0.0007
166 EYELID OEDEMA 8 0.0007
167 FOOT AMPUTATION 1 0.0007
168 LUMBAR SPINAL STENOSIS 2 0.0007
169 CEREBROVASCULAR DISORDER 2 0.0007
170 KERATITIS 2 0.0007
171 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
172 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
173 EYE ALLERGY 1 0.0006
174 NEOPLASM SKIN 1 0.0006
175 RENAL CYST 5 0.0006
176 TINEA PEDIS 1 0.0006
177 OPTIC NERVE DISORDER 1 0.0006
178 C-REACTIVE PROTEIN ABNORMAL 4 0.0006
179 VASOPLEGIA SYNDROME 1 0.0006
180 BREATH SOUNDS ABNORMAL 3 0.0006
181 DEMENTIA ALZHEIMER'S TYPE 1 0.0006
182 RECTAL ABSCESS 1 0.0006
183 DYSLIPIDAEMIA 3 0.0006
184 GLIOBLASTOMA 1 0.0006
185 RHEUMATOID ARTHRITIS 66 0.0006
186 CERVICAL SPINAL STENOSIS 1 0.0006
187 TONGUE COATED 1 0.0006
188 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
189 PRODUCT USE COMPLAINT 9 0.0006
190 EYE PAIN 31 0.0005
191 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
192 RETINAL OEDEMA 1 0.0005
193 FOOD ALLERGY 4 0.0005
194 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
195 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
196 CONCOMITANT DISEASE PROGRESSION 1 0.0005
197 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
198 OCULAR HYPERAEMIA 24 0.0005
199 BLEPHARITIS 2 0.0005
200 EYELID PAIN 1 0.0005
201 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
202 MOBILITY DECREASED 35 0.0005
203 SWELLING OF EYELID 3 0.0005
204 LATENT TUBERCULOSIS 1 0.0005
205 DILATATION VENTRICULAR 1 0.0005
206 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
207 PHARYNGEAL ERYTHEMA 1 0.0005
208 LYMPHOCYTOSIS 1 0.0005
209 CORNEAL DISORDER 1 0.0005
210 PRODUCT LOT NUMBER ISSUE 1 0.0005
211 CORNEAL OEDEMA 1 0.0004
212 EYELID DISORDER 1 0.0004
213 NERVE COMPRESSION 4 0.0004
214 EYE INFLAMMATION 4 0.0004
215 RADIUS FRACTURE 1 0.0004
216 GASTROINTESTINAL OBSTRUCTION 1 0.0004
217 PRODUCT PACKAGING CONFUSION 1 0.0004
218 VENTRICULAR HYPERTROPHY 1 0.0004
219 PARKINSON'S DISEASE 1 0.0004
220 DISSEMINATED TUBERCULOSIS 1 0.0004
221 VARICOSE VEIN 2 0.0004
222 BLOOD POTASSIUM ABNORMAL 1 0.0004
223 ERYTHEMA OF EYELID 2 0.0004
224 LARGE INTESTINAL ULCER 1 0.0004
225 LIP BLISTER 1 0.0004
226 SPINAL COMPRESSION FRACTURE 3 0.0004
227 VITREOUS HAEMORRHAGE 1 0.0004
228 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
229 HEART RATE ABNORMAL 2 0.0004
230 MACULAR OEDEMA 2 0.0004
231 EYE INFECTION 4 0.0004
232 VITAMIN D DECREASED 3 0.0004
233 GAIT DISTURBANCE 67 0.0003
234 DUODENAL ULCER HAEMORRHAGE 1 0.0003
235 PURPURA 3 0.0003
236 CHOLECYSTITIS 4 0.0003
237 PRODUCT SUBSTITUTION ISSUE 19 0.0003
238 EMERGENCY CARE 1 0.0003
239 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
240 EYE INJURY 1 0.0003
241 IRITIS 1 0.0003
242 EYE PRURITUS 11 0.0003
243 DUODENITIS 1 0.0003
244 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
245 FAMILY STRESS 1 0.0003
246 HYPERSENSITIVITY 59 0.0003
247 IRIDOCYCLITIS 1 0.0003
248 PRODUCT PACKAGING ISSUE 3 0.0003
249 POLYMYALGIA RHEUMATICA 1 0.0003
250 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
251 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
252 EYE DISCHARGE 3 0.0003
253 HYPERTENSION 61 0.0003
254 DIVERTICULUM 2 0.0003
255 OCULAR DISCOMFORT 3 0.0003
256 PHOTOPHOBIA 5 0.0003
257 PRODUCT STORAGE ISSUE 1 0.0003
258 FACE INJURY 1 0.0003
259 GINGIVAL DISORDER 1 0.0003
260 ACCIDENT 3 0.0003
261 CEREBRAL ATROPHY 1 0.0003
262 TRIGGER FINGER 1 0.0002
263 PHARYNGITIS 3 0.0002
264 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
265 ABNORMAL SENSATION IN EYE 1 0.0002
266 BLOOD MAGNESIUM DECREASED 2 0.0002
267 LACRIMATION INCREASED 7 0.0002
268 HIATUS HERNIA 3 0.0002
269 OCULAR ICTERUS 1 0.0002
270 HAEMORRHAGIC ANAEMIA 1 0.0002
271 LIMB DISCOMFORT 7 0.0002
272 GALLBLADDER DISORDER 4 0.0002
273 EAR DISORDER 1 0.0002
274 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
275 EYE OPERATION 1 0.0002
276 SYNOVIAL CYST 1 0.0002
277 CHOLELITHIASIS 7 0.0002
278 FLANK PAIN 2 0.0002
279 BLINDNESS UNILATERAL 3 0.0002
280 SPINAL COLUMN STENOSIS 1 0.0002
281 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
282 FAECAL INCONTINENCE 1 0.0002
283 SINUS BRADYCARDIA 2 0.0002
284 BODY TEMPERATURE DECREASED 2 0.0002
285 FLUID INTAKE REDUCED 1 0.0002
286 VEIN DISORDER 1 0.0002
287 CONDITION AGGRAVATED 60 0.0002
288 NEPHROLITHIASIS 9 0.0002
289 CEREBRAL ISCHAEMIA 1 0.0002
290 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
291 VENTRICULAR EXTRASYSTOLES 2 0.0002
292 POLYARTHRITIS 1 0.0002
293 EYE SWELLING 7 0.0002
294 ABSCESS 3 0.0002
295 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
296 ANAL FISSURE 1 0.0002
297 ANAL ABSCESS 1 0.0002
298 PRODUCT RESIDUE PRESENT 1 0.0002
299 CHOKING SENSATION 1 0.0002
300 NECROSIS 1 0.0002
301 SKIN INFECTION 2 0.0002
302 PERONEAL NERVE PALSY 1 0.0002
303 NEUTROPHILIA 1 0.0002
304 MICTURITION URGENCY 2 0.0002
305 CARDIAC VALVE DISEASE 1 0.0002
306 MUSCULOSKELETAL DISCOMFORT 3 0.0002
307 PNEUMONIA 56 0.0002
308 MADAROSIS 2 0.0002
309 RALES 1 0.0002
310 CATARACT OPERATION 1 0.0002
311 CARDIAC PACEMAKER INSERTION 1 0.0002
312 HYPERLIPIDAEMIA 2 0.0002
313 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
314 FIBROMYALGIA 4 0.0002
315 SCOLIOSIS 1 0.0002
316 INFUSION SITE EXTRAVASATION 1 0.0002
317 AGEUSIA 4 0.0002
318 BLEPHAROSPASM 1 0.0002
319 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
320 ENTERITIS 1 0.0002
321 PROCTALGIA 1 0.0002
322 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
323 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
324 VISION BLURRED 21 0.0002
325 WALKING AID USER 1 0.0002
326 PRODUCT FORMULATION ISSUE 1 0.0002
327 CARDIAC FAILURE ACUTE 1 0.0001
328 DYSGEUSIA 11 0.0001
329 WRONG PRODUCT ADMINISTERED 1 0.0001
330 UVEITIS 2 0.0001
331 PRODUCT LABEL ISSUE 1 0.0001
332 JOINT EFFUSION 1 0.0001
333 LYMPHOEDEMA 1 0.0001
334 HAIR GROWTH ABNORMAL 1 0.0001
335 PROCEDURAL PAIN 4 0.0001
336 HYPERKALAEMIA 5 0.0001
337 RETINAL HAEMORRHAGE 1 0.0001
338 LEUKOPENIA 7 0.0001
339 PANIC REACTION 1 0.0001
340 VISUAL FIELD DEFECT 1 0.0001
341 ANOSMIA 2 0.0001
342 ORAL DISORDER 1 0.0001
343 BLINDNESS TRANSIENT 1 0.0001
344 CATARACT 8 0.0001
345 LIPASE INCREASED 1 0.0001
346 CONCUSSION 1 0.0001
347 APHTHOUS ULCER 1 0.0001
348 BASAL CELL CARCINOMA 2 0.0001
349 DRUG INEFFECTIVE 168 0.0001
350 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
351 NASAL DISCOMFORT 1 0.0001
352 GINGIVAL PAIN 1 0.0001
353 CYSTITIS 4 0.0001
354 ATRIAL FLUTTER 1 0.0001
355 LOCALISED INFECTION 3 0.0001
356 MYASTHENIA GRAVIS 1 0.0001
357 POST PROCEDURAL INFECTION 1 0.0001
358 POLYURIA 1 0.0001
359 HICCUPS 1 0.0001
360 EYE DISORDER 4 0.0001
361 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
362 HAIR DISORDER 1 0.0001
363 VISUAL ACUITY REDUCED 4 0.0001
364 FACE OEDEMA 2 0.0001
365 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
366 PRODUCT USE ISSUE 22 0.0001
367 SCAR 2 0.0001
368 PSEUDOMONAS INFECTION 1 0.0001
369 CARDIAC MURMUR 1 0.0001
370 URINE OUTPUT DECREASED 1 0.0001
371 GROIN PAIN 1 0.0001
372 SPINAL OSTEOARTHRITIS 1 0.0001
373 TUMOUR LYSIS SYNDROME 1 0.0001
374 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
375 LIVER DISORDER 5 0.0001
376 VOMITING 53 0.0001
377 FACIAL PAIN 1 0.0001
378 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
379 MYOSITIS 1 0.0001
380 LIP DRY 1 0.0001
381 RESTLESS LEGS SYNDROME 2 0.0001
382 HYPERGLYCAEMIA 4 0.0001
383 EXOSTOSIS 1 0.0001
384 RETINAL DETACHMENT 1 0.0001
385 GRAND MAL CONVULSION 1 0.0001
386 SINUSITIS 11 0.0001
387 APPENDICITIS 1 0.0001
388 BLOOD SODIUM DECREASED 2 0.0001
389 MUSCULAR WEAKNESS 12 0.0001
390 SPUTUM DISCOLOURED 1 0.0001
391 BLOOD URINE PRESENT 2 0.0001
392 RECALLED PRODUCT ADMINISTERED 1 0.0001
393 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
394 HYPERCHOLESTEROLAEMIA 1 0.0001
395 EAR PAIN 2 0.0001
396 AUTOIMMUNE DISORDER 1 0.0001
397 PARKINSONISM 1 0.0001
398 PHARYNGEAL SWELLING 1 0.0001
399 VITREOUS FLOATERS 1 0.0001
400 THERAPY CHANGE 1 0.0001
401 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
402 SINUS DISORDER 2 0.0001
403 HYPOTONIA 1 0.0001
404 DRY EYE 5 0.0001
405 TOXIC SKIN ERUPTION 1 0.0001
406 DYSPNOEA 56 0.0001
407 HYPOTHERMIA 1 0.0001
408 FEEDING DISORDER 2 0.0001
409 EYELID PTOSIS 1 0.0001
410 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
411 BLINDNESS 4 0.0001
412 EPILEPSY 3 0.0001
413 FEELING HOT 6 0.0001
414 EAR DISCOMFORT 1 0.0001
415 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
416 RIB FRACTURE 2 0.0001
417 INFLAMMATION 5 0.0001
418 VISUAL IMPAIRMENT 12 0.0001
419 POOR VENOUS ACCESS 1 0.0001
420 TENDERNESS 1 0.0001
421 MOUTH ULCERATION 2 0.0001
422 HEAD INJURY 3 0.0001
423 POOR QUALITY SLEEP 2 0.0001
424 MELAENA 2 0.0001
425 HYPERTENSIVE CRISIS 1 0.0001
426 GAIT INABILITY 3 0.0001
427 PANCREATITIS ACUTE 2 0.0001
428 HEART RATE IRREGULAR 2 0.0001
429 MYOCARDIAL ISCHAEMIA 1 0.0001
430 MYOCARDITIS 1 0.0001
431 VASCULITIS 1 0.0001
432 RASH MACULAR 3 0.0001
433 HEART RATE DECREASED 3 0.0001
434 BLOOD PRESSURE INCREASED 13 0.0001
435 BACTERAEMIA 1 0.0001
436 ATAXIA 1 0.0001
437 DIABETIC KETOACIDOSIS 2 0.0001
438 NOCTURIA 1 0.0001
439 CARDIOMEGALY 1 0.0001
440 ABASIA 2 0.0001
441 CELLULITIS 4 0.0001
442 COLITIS 3 0.0001
443 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
444 DEAFNESS 2 0.0001
445 INCORRECT PRODUCT STORAGE 1 0.0001
446 GASTRITIS 2 0.0001
447 BRADYCARDIA 4 0.0001
448 HAIR TEXTURE ABNORMAL 1 0.0001
449 JOINT RANGE OF MOTION DECREASED 1 0.0001
450 OEDEMA PERIPHERAL 9 0.0001
451 LIMB INJURY 2 0.0001
452 ACUTE HEPATIC FAILURE 1 0.0001
453 SKIN LESION 2 0.0001
454 HYPOMAGNESAEMIA 1 0.0001
455 COORDINATION ABNORMAL 1 0.0001
456 APHONIA 1 0.0001
457 CARPAL TUNNEL SYNDROME 1 0.0001
458 OSTEOARTHRITIS 3 0.0001
459 LYMPHOPENIA 1 0.0001
460 RENAL FAILURE ACUTE 3 0.0001
461 PAIN IN JAW 2 0.0001
462 FLATULENCE 4 0.0001
463 URINARY TRACT INFECTION 12 0.0001
464 HYPOKINESIA 1 0.0001
465 FLUID OVERLOAD 1 0.0001
466 APATHY 1 0.0001
467 DYSSTASIA 2 0.0001
468 NASAL CONGESTION 4 0.0001
469 CARDIOMYOPATHY 1 0.0001
470 URINARY INCONTINENCE 2 0.0001
471 WHEEZING 4 0.0001
472 EPISTAXIS 5 0.0001
473 HYPOAESTHESIA ORAL 1 0.0001
474 CORONARY ARTERY DISEASE 2 0.0001
475 ECONOMIC PROBLEM 1 0.0001
476 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
477 TINNITUS 3 0.0001
478 EJECTION FRACTION DECREASED 1 0.0001
479 OFF LABEL USE 56 0.0001
480 CYANOSIS 1 0.0001
481 PAIN 39 0.0001
482 PNEUMOTHORAX 1 0.0001
483 SENSORY DISTURBANCE 1 0.0001
484 ALOPECIA 12 0.0001
485 IMPAIRED HEALING 2 0.0001
486 PHOTOSENSITIVITY REACTION 1 0.0001
487 BLOOD UREA INCREASED 1 0.0001
488 GASTRIC DISORDER 2 0.0001
489 DEVICE DEFECTIVE 1 0.0001
490 ABDOMINAL DISTENSION 6 0.0001
491 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
492 LYMPHADENOPATHY 2 0.0001
493 HEAD DISCOMFORT 1 0.0001
494 THIRST 1 0.0001
495 ARTHRALGIA 23 0.0001
496 OSTEOMYELITIS 1 0.0001
497 BONE DISORDER 1 0.0001
498 DYSURIA 2 0.0001
499 ADVERSE EVENT 5 0.0001
500 OROPHARYNGEAL PAIN 5 0.0001
501 CONJUNCTIVITIS 1 0.0001
502 BLISTER 3 0.0001
503 FRACTURE 1 0.0001
504 FOOT FRACTURE 1 0.0001
505 POST PROCEDURAL COMPLICATION 1 0.0001
506 ERUCTATION 1 0.0001
507 BACK PAIN 12 0.0001
508 ARTHRITIS 4 0.0001
509 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
510 JOINT SWELLING 6 0.0000
511 PRODUCT ADMINISTRATION ERROR 1 0.0000
512 EXTRA DOSE ADMINISTERED 2 0.0000
513 TASTE DISORDER 1 0.0000
514 VERTIGO 3 0.0000
515 DYSKINESIA 2 0.0000
516 PERITONITIS 1 0.0000
517 PULMONARY HYPERTENSION 1 0.0000
518 POLLAKIURIA 2 0.0000
519 ROAD TRAFFIC ACCIDENT 2 0.0000
520 BALANCE DISORDER 4 0.0000
521 AMNESIA 3 0.0000
522 MENTAL DISORDER 2 0.0000
523 PRODUCT DISPENSING ERROR 1 0.0000
524 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
525 PRODUCT STORAGE ERROR 4 0.0000
526 APPLICATION SITE PAIN 1 0.0000
527 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
528 RASH MACULO-PAPULAR 1 0.0000
529 CHROMATURIA 1 0.0000
530 PRODUCT QUALITY ISSUE 6 0.0000
531 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
532 ERYTHEMA 9 0.0000
533 MEMORY IMPAIRMENT 6 0.0000
534 SKIN IRRITATION 2 0.0000
535 CONFUSIONAL STATE 7 0.0000
536 WEIGHT DECREASED 12 0.0000
537 RENAL DISORDER 2 0.0000
538 SLEEP DISORDER 3 0.0000
539 ARRHYTHMIA 2 0.0000
540 FALL 14 0.0000
541 PRODUCT PRESCRIBING ERROR 1 0.0000
542 ABDOMINAL DISCOMFORT 7 0.0000
543 BLOOD PRESSURE FLUCTUATION 1 0.0000
544 PRESYNCOPE 1 0.0000
545 CEREBRAL INFARCTION 1 0.0000
546 PRODUCT DOSE OMISSION ISSUE 12 0.0000
547 PAIN IN EXTREMITY 12 0.0000
548 ENCEPHALOPATHY 1 0.0000
549 EXTRAPYRAMIDAL DISORDER 1 0.0000
550 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
551 HAEMATEMESIS 1 0.0000
552 COUGH 11 0.0000
553 HYPOPHAGIA 1 0.0000
554 CHEST DISCOMFORT 4 0.0000
555 ERECTILE DYSFUNCTION 1 0.0000
556 SKIN ULCER 1 0.0000
557 RASH GENERALISED 1 0.0000
558 EXPOSURE VIA SKIN CONTACT 1 0.0000
559 DIPLOPIA 1 0.0000
560 NERVOUSNESS 2 0.0000
561 SPEECH DISORDER 2 0.0000
562 JOINT STIFFNESS 1 0.0000
563 ANHEDONIA 1 0.0000
564 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
565 EAR INFECTION 1 0.0000
566 INSOMNIA 10 0.0000
567 BLOOD BILIRUBIN INCREASED 1 0.0000
568 RASH PRURITIC 2 0.0000
569 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
570 RESPIRATORY DISTRESS 1 0.0000
571 FEELING COLD 1 0.0000
572 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
573 PANCYTOPENIA 2 0.0000
574 THROMBOCYTOPENIA 4 0.0000
575 SKIN EXFOLIATION 3 0.0000
576 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
577 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
578 RED BLOOD CELL COUNT DECREASED 1 0.0000
579 ANGINA PECTORIS 1 0.0000
580 HYPERSOMNIA 1 0.0000
581 INTENTIONAL PRODUCT MISUSE 3 0.0000
582 DYSPHONIA 2 0.0000
583 CHILLS 4 0.0000
584 DIZZINESS 17 0.0000
585 LABORATORY TEST ABNORMAL 1 0.0000
586 RESPIRATORY DISORDER 1 0.0000
587 HYPOAESTHESIA 5 0.0000
588 BLOOD POTASSIUM DECREASED 1 0.0000
589 APHASIA 1 0.0000
590 ILL-DEFINED DISORDER 2 0.0000
591 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
592 FEMUR FRACTURE 1 0.0000
593 SWELLING 3 0.0000
594 SWOLLEN TONGUE 1 0.0000
595 DRUG-INDUCED LIVER INJURY 1 0.0000
596 DYSPHAGIA 3 0.0000
597 PULMONARY EMBOLISM 3 0.0000
598 NIGHT SWEATS 1 0.0000
599 RHINORRHOEA 2 0.0000
600 LACTIC ACIDOSIS 1 0.0000
601 DEEP VEIN THROMBOSIS 2 0.0000
602 PRODUCT DOSE OMISSION 2 0.0000
603 INFUSION RELATED REACTION 2 0.0000
604 BLOOD PRESSURE DECREASED 2 0.0000
605 EXPIRED PRODUCT ADMINISTERED 1 0.0000
606 LIP SWELLING 1 0.0000
607 DEHYDRATION 4 0.0000
608 SYNCOPE 3 0.0000
609 SKIN DISORDER 1 0.0000
610 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
611 FLUSHING 3 0.0000
612 DIARRHOEA 19 0.0000
613 MYALGIA 5 0.0000
614 HAEMATURIA 1 0.0000
615 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
616 BURNING SENSATION 2 0.0000
617 INJURY 2 0.0000
618 INFECTION 4 0.0000
619 CRYING 1 0.0000
620 HEPATIC FUNCTION ABNORMAL 1 0.0000
621 ASTHENIA 10 0.0000
622 DYSARTHRIA 1 0.0000
623 HOT FLUSH 2 0.0000
624 INTESTINAL OBSTRUCTION 1 0.0000
625 ANAEMIA 5 0.0000
626 PERIPHERAL SWELLING 4 0.0000
627 ABDOMINAL PAIN 6 0.0000
628 PALPITATIONS 3 0.0000
629 DISEASE PROGRESSION 3 0.0000
630 RASH 11 0.0000
631 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
632 DRY MOUTH 2 0.0000
633 RHABDOMYOLYSIS 1 0.0000
634 HEADACHE 15 0.0000
635 RENAL IMPAIRMENT 2 0.0000
636 PRURITUS 9 0.0000
637 LOSS OF CONSCIOUSNESS 3 0.0000
638 HYPOACUSIS 1 0.0000
639 SEPTIC SHOCK 1 0.0000
640 COVID-19 4 0.0000
641 PULMONARY OEDEMA 1 0.0000
642 THROAT IRRITATION 1 0.0000
643 INCORRECT DOSE ADMINISTERED 5 0.0000
644 SKIN DISCOLOURATION 1 0.0000
645 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
646 CHEST PAIN 4 0.0000
647 COGNITIVE DISORDER 1 0.0000
648 BLOOD GLUCOSE INCREASED 4 0.0000
649 DISEASE RECURRENCE 1 0.0000
650 MIGRAINE 2 0.0000
651 PRODUCTIVE COUGH 1 0.0000
652 RASH ERYTHEMATOUS 1 0.0000
653 FEELING ABNORMAL 5 0.0000
654 BLOOD GLUCOSE DECREASED 1 0.0000
655 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
656 HYPOGLYCAEMIA 1 0.0000
657 ATRIAL FIBRILLATION 2 0.0000
658 HEART RATE INCREASED 2 0.0000
659 HYPOTENSION 4 0.0000
660 SOMNOLENCE 4 0.0000
661 FLUID RETENTION 1 0.0000
662 HAEMOGLOBIN DECREASED 2 0.0000
663 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
664 MUSCULOSKELETAL PAIN 1 0.0000
665 PARAESTHESIA 3 0.0000
666 NAUSEA 15 0.0000
667 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
668 OEDEMA 1 0.0000
669 TREATMENT NONCOMPLIANCE 1 0.0000
670 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
671 FATIGUE 14 0.0000
672 INFLUENZA 2 0.0000
673 OXYGEN SATURATION DECREASED 1 0.0000
674 HYPONATRAEMIA 1 0.0000
675 HERPES ZOSTER 1 0.0000
676 LETHARGY 1 0.0000
677 PYREXIA 6 0.0000
678 DECREASED APPETITE 4 0.0000
679 IRRITABILITY 1 0.0000
680 NO ADVERSE EVENT 3 0.0000
681 EMOTIONAL DISTRESS 2 0.0000
682 THERAPEUTIC RESPONSE DECREASED 1 0.0000
683 STOMATITIS 1 0.0000
684 DISCOMFORT 1 0.0000
685 HYPERHIDROSIS 2 0.0000
686 DEVICE DIFFICULT TO USE 1 0.0000
687 THERAPY INTERRUPTED 1 0.0000
688 SKIN BURNING SENSATION 1 0.0000
689 RESPIRATORY FAILURE 1 0.0000
690 UNDERDOSE 1 0.0000
691 WEIGHT INCREASED 3 0.0000
692 DEPRESSION 3 0.0000
693 CARDIAC FAILURE CONGESTIVE 1 0.0000
694 PROSTATE CANCER 1 0.0000
695 INFLUENZA LIKE ILLNESS 1 0.0000
696 CARDIAC ARREST 1 0.0000
697 DRUG DOSE OMISSION 2 0.0000
698 TOXICITY TO VARIOUS AGENTS 2 0.0000
699 MYOCARDIAL INFARCTION 2 0.0000
700 MALAISE 5 0.0000
701 TACHYCARDIA 1 0.0000
702 ADVERSE DRUG REACTION 1 0.0000
703 NASOPHARYNGITIS 2 0.0000
704 ANXIETY 3 0.0000
705 NEUROPATHY PERIPHERAL 1 0.0000
706 CONTUSION 1 0.0000
707 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
708 ABDOMINAL PAIN UPPER 2 0.0000
709 HAEMORRHAGE 1 0.0000
710 PLATELET COUNT DECREASED 1 0.0000
711 OVERDOSE 2 0.0000
712 CONSTIPATION 2 0.0000
713 SEPSIS 1 0.0000
714 ASTHMA 1 0.0000
715 SEIZURE 1 0.0000
716 INJECTION SITE ERYTHEMA 1 0.0000
717 PSORIASIS 1 0.0000
718 DRY SKIN 1 0.0000
719 ACUTE KIDNEY INJURY 1 0.0000
720 HOSPITALISATION 1 0.0000
721 DRUG INTERACTION 1 0.0000
722 TREMOR 1 0.0000
723 URTICARIA 1 0.0000
724 CEREBROVASCULAR ACCIDENT 1 0.0000
725 MUSCLE SPASMS 1 0.0000
726 INJECTION SITE PAIN 1 0.0000
727 DEATH 1 0.0000